Transaction details
Director Capone Mark Christopher acquired 1,301 shares of Mesa Laboratories Inc. /CO/ (NASDAQ:MLAB) on March 10, 2026, as disclosed in a Form 4 filing with the Securities and Exchange Commission. The filing shows the shares were purchased at $76.35 each, bringing the transaction value to $99,331.
Following this purchase, Capone Mark Christopher directly owns 3,429 shares of Mesa Laboratories. The insider buy came at a moment of recent share weakness - the stock had fallen nearly 20% over the preceding week, and was reported trading at $73.47.
Valuation signals and investor tools
According to InvestingPro analysis cited in the filing context, MLAB appears undervalued at current levels. The same analysis assigns the company a "GOOD" financial health score of 2.71. InvestingPro also provides additional material for investors, including nine exclusive tips tied to MLAB, which highlight the company’s high shareholder yield and its 24-year streak of dividend payments.
Leadership transition
In separate corporate developments, Mesa Laboratories announced a change in executive leadership. Gary Owens has stepped down from his roles as President and Chief Executive Officer. The company’s Board of Directors appointed Dr. Siddhartha Kadia as President and Chief Executive Officer, effective April 13, 2026. Dr. Kadia will also serve on the company’s Board of Directors.
The company characterized the appointment as a notable development as Mesa moves forward under new executive management. The statement indicates that investors and stakeholders will be watching how Dr. Kadia’s leadership influences the company’s future direction.
Context and note
The information above is taken from the Form 4 filing and the company’s announcement of its CEO transition. No additional claims or forecasts about future performance are made beyond these disclosures.
Source documents referenced
- Form 4 filing disclosing Capone Mark Christopher's purchase on March 10, 2026
- Company announcement of leadership change effective April 13, 2026